TrialClinical cancer research : an official journal of the American Association for Cancer Research2022

Functional Mapping of AKT Signaling and Biomarkers of Response from the FAIRLANE Trial of Neoadjuvant Ipatasertib plus Paclitaxel for Triple-Negative Breast Cancer.

Zhen Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.